BOI Chairman Susantha Ratnayake (left) formally hands over the certificate of registrations to Sands Active Director Dr. Anoopkanth Segar
The Board of Investment of Sri Lanka has signed an agreement with Sands Active Ltd., to set up a project for the manufacture of pharmaceutical products for the local market to meet the current national requirement of imports substitution of medicinal drugs.
The agreement was signed on behalf of the BOI by Chairman Susantha Ratnayake, and on behalf of the Company Director Dr. Anoopkanth Segar. The total value of this agreement is $ 10.1 million and the project will provide employment to 160 workers.
Sands Active Ltd. was established as a private limited company in year 2018. The company is in the process of setting up a state-of-the-art factory with the latest technology and cutting-edge manufacturing capabilities to manufacture pharmaceutical products, in order to cater for the Sri Lankan market and also export markets. The Company has the ambition of supplying quality and affordable pharmaceutical products to the local population, and reaching the export market too. While providing the best quality at affordable price, the company believes in honesty and integrity when reaching their customers. The company considers itself duty-bound to ensure that all levels of staff such as doctors, chemists, patients, hospitals, medical centres and pharmacies are covered during its responsible reach.
Sands Active Ltd. will also continue to build skills for innovation through R&D, to maintain its standards in the years to come. The coming up factory facility will manufacture oral tablets, capsules, injectables, liquid syrups, and small volume parenterals with future expansions in mind. This modern state-of-the-art facility will follow WHO CGM Regulations to ensure quality drugs, throughout their entire manufacturing process.
Sands Active is in a mission to shape up the country’s health care, enriching lives of the Sri Lankan people.